Akeso Biomedical's Unattributed - III Round

Akeso Biomedical raised a round of funding on March 17, 2017.

Akeso Biomedical is developing a new generation of compounds, known as Fe3C, with broad-spectrum activity to fight bacterial infections, and prevent foodborne illnesses. The company's technology is be…

Articles about Akeso Biomedical's Unattributed - III Round: